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Abstract  
BACKGROUND: The proportion of T and B lymphocytes in pleural fluids and blood may point to 
the presence of local immunological phenomena in pleural disorders. 
AIM: Aim of study was to evaluate the lymphocyte phenotype and the ratio between helper (CD4+) 
and cytotoxic/suppressor (CD8+) lymphocytes in malignant and non-malignant effusions. 
MATERIAL AND METHODS: We studied 48 patients with pleural effusions. First group had 18 
patients with tuberculosis pleural effusions; second group had 20 patients with malignant pleural 
fluids, third group had 10 patients with transudates and 30 healthy controls. We investigated the 
distribution of T and B lymphocytes, T cells with helper/inducer CD4 or suppresser/cytotoxic CD8 
phenotypes and the CD16 subset. 
RESULTS: Results showed decreases levels of CD3, CD4, and CD16 T cells in blood of patients 
versus healthy controls. There were increases in the percentage of the CD3 and CD4 T cells in the 
pleural fluid compared with values in the blood with statistical significance in tuberculous pleurisy. 
The values of CD8 were similar in the pleural fluid and in blood. Levels of CD16 were non-
significantly higher in pleural fluid in all groups. 
CONCLUSION: This study confirms the hypothesis that pleural cavity is compartment with 
immunological reactivity and results could be used in differential diagnosis together with other 
examinations.  
 
 
 
 
 
 
Introduction 
 
Lymphocytes are the primary effectors of 
cellular and humoral immunocompetence in humans. 
Lymphocytic pleural effusions are characterized by 
divergent cellular responses depending on the 
etiology of disease [1]. The accumulation of fluid in the 
pleural space indicates the presence of systemic or 
local disease. Pleural exudates involve the migration 
of immune cells to the pleural cavity [2]. Lymphocytes 
dominance occurs in the most chronic pleural 
effusions [3, 4]. The proportion of T and B 
lymphocytes in pleural fluids relative to that in 
peripheral blood may point to the presence of local 
immunological phenomena in various pulmonary and 
pleural disorders. Tuberculosis and malignant disease 
are among most frequent causes of pleural effusions. 
In both causes, the pleural fluid is generally 
lymphocytic, with predominance of T lymphocytes, 
particularly CD4+ positive T cells [2, 5, 6]. Malignant 
effusions are a relatively easily accessible source of 
tumor-associated T cells and this represent a suitable 
model for the study of interactions between tumor 
cells and the host immune system [7].  
Considering the compartmentalization of the 
pleural space, the association between the local and 
systemic cellular responses should be analyzed. 
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Material and Methods  
 
We have investigated the distribution of T and 
B lymphocytes, T cell with helper/inducer CD4+ or 
suppresser/cytotoxic CD8+ phenotypes and the 
subset of cells with natural killer NK activity. We have 
used the analysis of T cell subsets by monoclonal 
antibodies defined markers. We studied 48 patients 
from Clinic of Pulmonology and Allergology with 
pleural effusions, divided in three groups. First group 
had 18 patients with tuberculous pleural effusions, 
Second group had 20 patients with malignant pleural 
effusions (mesothelioma, lung carcinoma or 
metastatic pleural effusions) and third group had 10 
patients with transudates secondary to cardiac failure. 
We have also examined a group of 30 healthy 
controls.  
In our study we evaluated:  
1) the frequency of lymphocyte predominance in 
different malignant and non-malignant pleural 
effusions;  
2) lymphocyte phenotype and the ratio between 
helper (CD4+) and cytotoxic/suppressor 
(CD8+) lymphocytes in malignant and non-
malignant effusions. 
Results were statistically elaborated according to 
the Student t-test and Analysis of Variance (ANOVA).  
 
 
Results 
 
According to our results there were a 
significant decrease of the levels of CD3, CD4, CD16 
and CD22 positive cells in peripheral blood of patients 
with tuberculous pleural effusions versus healthy 
controls (Table 1). It is due to suppresser activity of 
lymphocytes in peripheral blood, but also to the 
immunological reactivity of the pleural effusions.  
Table 1: Values of CD markers in blood of patients with 
tuberculous effusion versus healthy controls 
  CD3% CD4% CD8% CD16% CD22% CD4/CD8 
Controls (N=30) 65 38 23 15 15 1.65 
Tuberculous (N=18) 59.33 31.66 22 12.67 11.78 1.44 
t-test 2.31 2.91 0.56 2.09 2.06  
Significance S S NS S S  
 
Evaluation of the values of CD markers in 
peripheral blood with malignant effusions versus 
healthy controls, demonstrate significant decrease in 
patients with malignant effusions only for CD22 cells. 
Changes of the values for CD3, CD4, CD8 and CD16 
T cells were not significant (Fig. 1) 
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Figure 1: Values of CD markers in the peripheral blood of patients 
with malignant pleural effusions versus values of CD markers in 
peripheral blood in healthy controls 
 
Values of CD markers in peripheral blood with 
transudates versus healthy controls demonstrate 
significant decrease in patients with transudates only 
for CD22 cells. Changes of the values for CD3, CD4, 
CD8 and CD16 T cells were not significant (Table 2). 
Table 2: Values of CD markers in blood of patients with 
transudates versus healthy controls 
  CD3% CD4% CD8% CD16% CD22% CD4/CD8% 
Controls (N=30) 65 38 23 15 15 1.65 
Transudates (N=10) 59.6 33.2 22.6 13.4 9.2 1.6 
T-test 1.63 0.62 0.17 1.36 3.21  
Significance NS NS NS NS S  
 
In our study, the analysis of the values of CD 
markers in patients with tuberculous effusions, 
demonstrate significant increase of the percentage of 
CD3 and CD4 in the pleural fluid versus blood. We 
also noticed significant decrease of CD22 cells in 
pleural tuberculous effusion (p<0.05) (Fig. 2). 
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Figure 2: Values of CD markers in blood and pleural effusions in 
patients with tuberculous pleurisy  
 
In patients with malignant effusions, we 
noticed increase of the values of CD3, CD4, CD8 and 
CD16 cells in the pleural malignant fluid versus blood, 
but these changes were not significant, (p<0.05) 
(Table 3). 
Table 3: Comparison of values of CD markers in blood and 
pleural effusions in patients with malignant effusion 
 CD3% CD4% CD8% CD16% CD22% CD4/CD8% 
Blood 63 33.8 24 13 9.7 1.41 
Malignant effusion 67.68 38.63 25.37 15.67 7.67 1.52 
T- test 1.18 1.62 0.66 1.42 1.26  
Significance NS NS NS NS NS  
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According to our results, in patient with 
transudates, the values of CD3, CD4, CD8 and CD16 
cells were not significantly changed, (p<0.05) (Fig. 3). 
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Figure 3: Values of CD markers in blood and pleural effusions in 
patients with transudates 
 
 
Discussion 
 
This study evaluated the concept of 
compartments and it also investigated the significance 
of immunological reactivity of pleura. In our study, 
according to our results, there was a significant 
decrease of the levels of CD3, CD4, CD16 and CD22 
positive lymphocyte cells in peripheral blood of 
patients with tuberculous pleural effusion versus 
healthy controls. Shiratusci in his study demonstrate 
the evaluation of the values of the lymphocyte subsets 
and there are noticed the decrease of values of CD3 
and CD4 cells in patients with tuberculosis versus 
healthy subjects [8]. Compared with controls, the 
cases showed total lymphocytopenia in peripheral 
blood and also major depletion of the peripheral T 
lymphocytes [9].  
According to our results, in patients with 
malignant pleural effusion we noticed decreased 
values for CD3, CD4 and CD16 positive T cells versus 
healthy subjects and increases for CD8 positive T 
cells, but there were not significant. We noticed 
significant decrease only for CD22 lymphocytes. In 
literature it was observed lower percentage of CD4+ 
lymphocytes subsets and higher percentage of CD8+ 
lymphocytes subsets in malignant when compared to 
non-malignant fluids [10]. Values of CD markers in 
peripheral blood with transudates versus healthy 
controls demonstrate significant decrease in patients 
with transudates only for CD22 cells. Changes of the 
percentage for CD3, CD4, CD8 and CD16 positive T 
cells were not significant due to low inflammatory 
reactivity in the pleural space of patients with cardiac 
failure. 
In our study, the analysis of the values of CD 
markers in patients with tuberculous effusions, 
demonstrate significant increase of the values of CD3 
and CD4 positive cells in the pleural fluid versus 
blood. We also noticed significant decrease of the 
percentage of CD22 cells in pleural tuberculous 
effusion versus blood. In literature, it is demonstrated 
that pleural involvement is associated with migration 
of immune cells to the pleural cavity [2] and it is 
noticed the predominance of T helper cells into pleural 
space [11-13].
 
The lymphocytic subpopulation study 
confirms the concept of compartmentalization in 
tuberculous pleuritis, as shown by the greater number 
of activated T lymphocytes present in pleural fluid in 
comparison with peripheral blood in patients with 
tuberculous pleural effusions [14]. and predominance 
of helper cells (CD4+) in pleural fluid [12, 14, 15]. 
According our study the CD4/CD8 ratio was greater in 
pleural fluid then in peripheral blood as it is known in 
literature [14]. 
In patients with malignant effusions, we 
noticed increase of the values of CD3, CD4, CD8 and 
CD16 positive T cells in the pleural malignant fluid 
versus blood, but these changes were not significant 
due to different etiologies of malignancy. Some 
authors demonstrate increased CD4+ T lymphocyte 
subset in malignant pleural effusion [16, 17]. In the 
literature there are similar findings with explanation 
that it is due to suppresser activity of lymphocytes in 
peripheral blood, but also to the immunological 
reactivity of the pleural effusions [18]. In malignant 
effusions, the inflammatory processes and the 
immune responses induce the recruitment of cells into 
the pleural space [19]. The levels of CD16 (NK cells) 
were non-significantly higher in pleural fluid in all three 
groups and it show that they have not a relevant role 
in immunological reactivity of the pleura and diagnosis 
of pleurisy. Some authors found that despite a higher 
percentage of circulating NK cells in patients with 
pleural malignancies than in healthy subjects, there 
was a defect in recruiting NK cells in malignant pleural 
effusions [11, 20]. 
The patients with transudates secondary to 
cardiac failure have very small difference of the values 
versus other groups that is according to low 
immunological and inflammatory reactivity in the 
pleural space of these patients. 
 In conclusion, the values of CD3 and CD4 
positive T cells were significantly higher in the pleural 
fluid of patients with tuberculous pleural effusions. The 
results suggest that the responding T lymphocytes 
have been portioned from the peripheral blood to the 
site of inflammation. The lymphocytes 
chemoattractans are present in the pleural fluid and 
these factors enhance the accumulation of T cells to 
the pleural cavity (especially in patients with 
tuberculous pleuricity). The patients with transudates 
secondary to cardiac failure have very small 
difference between the percentages in all three 
groups. We can say that this study confirms the 
hypotheses that the pleural cavity is compartment with 
its own immunological reactivity. The results of this 
study could be used in differential diagnosis only 
together with other clinical and biochemical 
examinations. 
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